Home
Conditions
IgA Nephropathy (IgAN)

Clinical trial condition

IgA Nephropathy (IgAN)

Explore clinical trials studying IgA Nephropathy (IgAN). Study availability and eligibility vary by location and protocol.

36 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

IgA Nephropathy (IgAN) trial results

Not yet recruiting

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

NCT07555301

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Stadtspital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not yet recruiting

SLN12140 in Adult Participants With IgA Nephropathy in China

NCT07553494

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Beijing University 1st hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

NCT07535138

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +16 more
Locations: Xijing Hospital Xi'an, Shaanxi, China

View Trial Details

Not yet recruiting

A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

NCT07445906

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

NCT07360002

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

NCT07052981

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

NCT06687174

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by invitation

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

NCT06674577

Conditions: Autoimmune Diseases, Berger Disease, Female Urogenital Diseases, +11 more
Locations: Vera Therapeutics Brisbane, California, United States

View Trial Details

Active, not recruiting

Model Development and Application Based on Renal Pathology Images

NCT07816874

Conditions: Autoimmune Diseases, Chronic Disease, Disease Attributes, +20 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Active, not recruiting

A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases

NCT06786338

Conditions: Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +11 more
Locations: Peking University First Hospital Beijing, China

Peking University People's Hospital Beijing, China

The Third Xiangya Hospital of Central South University Changsha, China

Sichuan Provincial People's Hospital Chengdu, China

View Trial Details

IgA Nephropathy (IgAN)

IgA Nephropathy (IgAN) trial results

Related conditions